Top Analysis Stories
Analysis
Pharma middlemen's cut is getting bigger, at least in NY
By Robert LangrethAccording to an new analysis, drug markups by PBMs in New York more than doubled from 2016 to 2017.
According to an new analysis, drug markups by PBMs in New York more than doubled from 2016 to 2017.